Our CEO Kono presents at a symposium of the Japanese Society for Neuroendovascular Therapy annual meeting (JSNET2023)

We are pleased to announce that our CEO Kono gave a symposium presentation at the 39th Annual Meeting of the Japanese Society for Neuroendovascular Therapy (JSNET2023).

■About the 39th Annual Meeting of the Japanese Society for Neuroendovascular Therapy Held from November 23 to 25, 2023, it is Japan’s largest academic meeting in neuroendovascular therapy. Our CEO Kono presented at a symposium. The Company also had a booth exhibit. Fri, Nov 24, 10:10 — Development of the AI-based neuroendovascular therapy support medical device software Neuro-Vascular Assist: from founding the company to regulatory approval http://jsnet2023.umin.jp/index.html In addition, three AI-related presentations from the Company were given.

■iMed Technologies, Inc. Company Profile Company name: iMed Technologies, Inc. Address: 2F Rune Yushima Building, 4-1-13 Yushima, Bunkyo-ku, Tokyo Founded: April 1, 2019 Business: Development of surgical support AI for endovascular surgery Representative: Representative Director and CEO, physician Kenichi Kono

Inquiries: info@imed-tech.co.jp